Tradestie Institutional Equity Comparison Engine · Market Close Nov 19, 2026
HSDT vs NUWE: Which Stock Is the Better Buy Now?
Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.
HSDT Wins Head-to-Head Institutional Verdict (3–2 across 6 Pillars · 7–2 Matrix Metrics)
HSDT Overall Winner
6-Pillar Tally: HSDT 3 – 2 NUWE (1 Tie)
Matrix Metrics: HSDT 7 – 2 NUWE
As of Nov 19, 2026, Solana Company (HSDT) is the stronger overall head-to-head candidate over Nuwellis, Inc. (NUWE) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HSDT carries a Unified Composite Score of 59.0/100 (HOLD) at $1.66 (N/M Forward P/E, -1557.5% operating margin), whereas NUWE carries 37.8/100 (SELL) at $3.81 (N/M Forward P/E, -142.9% operating margin).
- Technical & Structure Timing Caution: HSDT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 29.4); meanwhile NUWE trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 51.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
Executive Snapshot Side-by-Side Composite Ratings & Technical Regime
Ask Alpha AI About HSDT vs NUWE
HSDT
Head-to-Head Winner
Solana Company Class A Common Stock (DE)
$1.66
+1.84% 1D
Market Cap
$103.1M
TTM Revenue
$272M
Forward P/E
N/M
Beta / 30D Vol
2.20β · 55% Vol
Unified Composite Score
59.0
HOLD
Tech 60.0
Fund 53.0
Flow 58.0
Mom 55.0
Weinstein Technical Phase
Markdown · Sell / avoid
NUWE
Nuwellis, Inc. Common Stock
$3.81
-2.06% 1D
Market Cap
$2.1M
TTM Revenue
$9.0M
Forward P/E
N/M
Beta / 30D Vol
-8.47β · 4990% Vol
Unified Composite Score
37.8
SELL
Tech 15.0
Fund 33.0
Flow 50.0
Mom 40.0
Weinstein Technical Phase
Markup · Hold / add on dips
6-Pillar Scorecard Institutional Category Breakdown (HSDT 3 – 2 NUWE)
1. Valuation Multiples
HSDT
Forward P/E
N/M
N/M
Trailing P/E
0.0x
N/M
PEG Ratio
N/M
N/M
EV / Revenue
0.4x
N/M
2. Growth & Scale
HSDT
Revenue Growth (YoY)
+382.1%
+14.1%
Earnings Growth (YoY)
+0.0%
-99.2%
TTM Revenue (USD)
$272M
$9.0M
Market Cap
$103.1M
$2.1M
3. Profitability & Quality
HSDT
Gross Margin
92.8%
69.7%
Operating Margin
-1557.5%
-142.9%
Net Profit Margin
2040.4%
-125.6%
Return on Equity (ROE)
52.8%
-609.4%
4. Balance Sheet & Cash Flow
NUWE
Cash Generation (TTM)
-$4.22B EBITDA
-$13M EBITDA
Cash Flow Margin
N/A
-141.2% EBITDA Mgn
Net Cash / Leverage
$4.38 Book/Sh · 52.8% ROE
$3.7M Net Cash
Dividend Yield
None (0.00%)
None (0.00%)
5. Options & Positioning
NUWE
Options Structure Phase
BREAKDOWN
UNCLASSIFIED
Current IV / %ile
540.7% (85th %ile)
N/A (N/A)
Put/Call OI Skew
7.50x (Put-Skewed)
N/A
OBV Trend / Tech Phase
DISTRIBUTION · Markdown
NEUTRAL · Markup
6. R&D & Supply-Chain Moat
Tie
OpEx & R&D Intensity
N/A
N/A
90D R&D Disclosures
0 papers
0 papers
Competitive Moat
High-Margin Pricing Power Moat
Cyclical / Execution-Driven Positioning
Supply-Chain Role
Asset Management Operator
Medical Devices Operator
Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table
Core Matrix Wins: HSDT (7) vs NUWE (2)| Institutional Metric | HSDT | NUWE | Criterion | Row Edge |
|---|---|---|---|---|
| Market Capitalization | $103.1M | $2.1M | HSDT | |
| Trailing P/E Ratio | 0.0x | N/M | HSDT | |
| Forward P/E Ratio | N/M | N/M | Tie | |
| Revenue Growth (YoY) | +382.1% | +14.1% | HSDT | |
| Operating Margin (TTM) | -1557.5% | -142.9% | NUWE | |
| Net Profit Margin | 2040.4% | -125.6% | HSDT | |
| Return on Equity (ROE) | 52.8% | -609.4% | HSDT | |
| 52-Week Range Position | 15% ($1–$4) | 53% ($0–$7) | NUWE | |
| Beta / 30D Volatility | 2.20β · 55% Vol | -8.47β · 4990% Vol | HSDT | |
| Unified Institutional Score | 59.0 / 100 (HOLD) | 37.8 / 100 (SELL) | HSDT | |
| Trailing 12M Revenue (USD) | $272M | $9.0M | Scale | |
| Gross Profit Margin (TTM) | 92.8% | 69.7% | Quality | |
| PEG Ratio & EV / Revenue | N/M PEG · 0.4x EV/Rev | N/M PEG · N/M EV/Rev | Valuation | |
| Cash Flow & Balance Sheet | -$4.22B EBITDA ($4.38 Book/Sh · 52.8% ROE) | -$13M EBITDA ($3.7M Net Cash) | Solvency |
Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)
1M Horizon
NUWE +660.1 pp
3M Horizon
NUWE +249.4 pp
6M Horizon
NUWE +312.0 pp
1Y Horizon
NUWE +119.94 pp
Financial Trajectory Multi-Year Annual Revenue & Operating Margin Trajectory (USD)
| Period | HSDT Revenue | NUWE Revenue | HSDT Op. Margin | NUWE Op. Margin | Margin Leader |
|---|---|---|---|---|---|
| FY2018 | $0M | $0M | -5580.5% | -340.9% | NUWE |
| FY2019 | $0M | $10M | -1604.0% | -328.5% | NUWE |
| FY2020 | $0M | $10M | -2176.4% | -228.8% | NUWE |
| FY2021 | $0M | $10M | -3679.9% | -246.5% | NUWE |
| FY2022 | $0M | $10M | -1994.3% | -201.0% | NUWE |
| FY2023 | $0M | $10M | -2054.2% | -198.9% | NUWE |
| FY2024 | $0M | $10M | -2673.7% | -125.7% | NUWE |
| FY2025 | $0M | $10M | -44496.4% | -134.3% | NUWE |
Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor
Live Options Phase Tracker
HSDT
BREAKDOWN
Current IV
540.7%
IV Percentile
85th %ile
Put/Call OI Skew
7.50x (Put-Skewed)
IV Regime
Extreme (>80th %ile)
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
BULLISH
OBV Flow
DISTRIBUTION
Exact HSDT Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
NUWE
UNCLASSIFIED
Current IV
N/A
IV Percentile
N/A
Put/Call OI Skew
N/A
IV Regime
Unclassified
Put Wall Floor
Pro Only
Call Wall Magnet
Pro Only
Net Delta Signal
NEUTRAL
OBV Flow
NEUTRAL
Exact NUWE Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro.
Unlock 14-Day Free Trial →
Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity
Corporate R&D & Foundry Leaderboard
HSDT Moat Profile
High-Margin Pricing Power Moat
Asset Management Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
NUWE Moat Profile
Cyclical / Execution-Driven Positioning
Medical Devices Operator
OpEx & R&D Reinvestment
N/A
90D Engineering Disclosures
0 Published
Investor FAQ HSDT vs NUWE Key Questions & Quantitative Answers
As of Nov 19, 2026, Solana Company (HSDT) is the stronger overall head-to-head candidate over Nuwellis, Inc. (NUWE) in the Tradestie Institutional Equity Comparison Engine, winning 7–2 core matrix metrics and 3–2 across our 6-pillar institutional scorecard (led by Valuation Multiples, Growth & Scale, Profitability & Quality). HSDT carries a Unified Composite Score of 59.0/100 (HOLD) at $1.66 (N/M Forward P/E, -1557.5% operating margin), whereas NUWE carries 37.8/100 (SELL) at $3.81 (N/M Forward P/E, -142.9% operating margin). Technical & Structure Timing Caution: HSDT is currently in a short-term Weinstein Markdown pullback below its falling 50-day moving average and Breakdown options structure phase (RSI 29.4); meanwhile NUWE trades in a Markup technical trend (UNCLASSIFIED options phase, RSI 51.1). Short-term Markdown, Distribution, or Breakdown phases signal active supply overhead rather than bullish technical support — disciplined entries typically wait for price to reclaim the 20/50-day moving average.
HSDT leads the Growth & Scale pillar: HSDT posts +382.1% YoY revenue growth and +0.0% YoY earnings growth on $272M TTM revenue (92.8% gross margin, -1557.5% operating margin), compared with NUWE at +14.1% YoY revenue growth and -99.2% YoY earnings growth on $9.0M TTM revenue (69.7% gross margin, -142.9% operating margin). Across the 8-period historical trajectory (FY2018 to FY2025), HSDT cumulative revenue shifted N/A while NUWE shifted +0.0%. In operating R&D and SG&A reinvestment, HSDT deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for NUWE.
HSDT screens cheaper on headline valuation multiples. HSDT trades at N/M Forward P/E, 0.0x Trailing P/E, N/M PEG, and 0.4x EV/Revenue (unreported EBITDA margin), whereas NUWE trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (-141.2% EBITDA margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against HSDT (52.8% ROE) versus NUWE (-609.4% ROE) capital efficiency.
In options market volatility and institutional positioning, HSDT carries 540.7% implied volatility (85th %ile, Extreme (>80th %ile)), a 7.50x (Put-Skewed) Put/Call open-interest ratio, DISTRIBUTION on-balance volume, and sits in a BREAKDOWN options structure phase (2.20β · 55% Vol realized risk). By comparison, NUWE carries N/A implied volatility (N/A, Unclassified), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-8.47β · 4990% Vol realized risk).
Cross-Compare 1-Click Peer Rivalries & Single-Stock Research
Launch Custom Ticker Comparison →
NUWE vs HSDT · Reverse Pair
HSDT vs QNRX
· Sector Peer
NUWE vs SHPH
· Sector Peer
NUWE vs QNRX
· Sector Peer
INTC vs AMD
· x86 & Data Center CPU
NVDA vs AMD
· AI Accelerators
TSM vs ASML
· Foundry & Lithography
MSFT vs GOOGL
· Hyperscale Cloud & AI
AAPL vs META
· Consumer Ecosystem
LLY vs NVO
· GLP-1 Biopharma
AVGO vs MRVL
· Custom ASIC & Networking